CAS 32581-31-0

Formule : C18H32O16

InChI : InChI=1S/C18H32O16/c19-1-5(22)9(24)16(6(23)2-20)34-18-15(30)13(28)11(26)8(33-18)4-31-17-14(29)12(27)10(25)7(3-21)32-17/h1,5-18,20-30H,2-4H2/t5-,6+,7+,8+,9+,10-,11-,12-,13-,14+,15+,16+,17+,18-/m0/s1

Code InChI : ZCLAHGAZPPEVDX-WGLZGUASSA-N

SMILES : C([C@@H]1[C@@H]([C@@H]([C@H]([C@@H](O1)OC[C@@H]2[C@@H]([C@@H]([C@H]([C@@H](O2)O[C@H]([C@@H](CO)O)[C@@H]([C@H](C=O)O)O)O)O)O)O)O)O)O

(2R,3R,4R,5R)-2,3,5,6-Tetrahydroxy-4-(((2S,3R,4S,5R,6R)-3,4,5-trihydroxy-6-((((2R,3R,4S,5R,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-2-yl)oxy)methyl)tetrahydro-2H-pyran-2-yl)oxy)hexana

CAS : 32581-31-0

(2R,3R,4R,5R)-2,3,5,6-Tetrahydroxy-4-(((2S,3R,4S,5R,6R)-3,4,5-trihydroxy-6-((((2R,3R,4S,5R,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-2-yl)oxy)methyl)tetrahydro-2H-pyran-2-yl)oxy)hexana

Formule : C₁₈H₃₂O₁₆

Degré de pureté : 98%

Masse moléculaire : 504.44

Ref: 54-OR1175790

(2R,3R,4R,5R)-2,3,5,6-Tetrahydroxy-4-(((2S,3R,4S,5R,6R)-3,4,5-trihydroxy-6-((((2R,3R,4S,5R,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-2-yl)oxy)methyl)tetrahydro-2H-pyran-2-yl)oxy)hexanal

CAS : 32581-31-0

Degré de pureté : 98%

Ref: IN-DA01EAHF

6'-Galactosyllactose

CAS : 32581-31-0

Formule : C₁₈H₃₂O₁₆

Degré de pureté : 95%~99%

Masse moléculaire : 504.438

Ref: BP-BPL0107

6'-Galactosyllactose

CAS : 32581-31-0

Formule : C₁₈H₃₂O₁₆

Masse moléculaire : 504.44

Ref: 4Z-L-092022

6'-(D-[UL-13C6]Galactosyl)lactose

CAS : 32581-31-0

Galactosyllactose attenuated NF-κB inflammatory signaling in human intestinal epithelial cells and in human immature intestine. Thus, galactosyllactoses are strong anti-inflammatory agents in human colostrum and early milk, contributing to innate immune modulation. This product has a 13C heavy-label and so can be used in applications such as metabolic tracing and quantitative mass spectrometry.

Formule : C₆C₁₂H₃₂O₁₆

Degré de pureté : Min. 90 Area-%

Masse moléculaire : 510.39 g/mol

Ref: 3D-OG15067

6'-Galactosyllactose

CAS : 32581-31-0

Galactosyllactose attenuated NF-κB inflammatory signaling in human intestinal epithelial cells and in human immature intestine. Thus, galactosyllactoses are strong anti-inflammatory agents in human colostrum and early milk, contributing to innate immune modulation. The potential clinical utility of galactosyllactose warrants investigation.

Formule : C₁₈H₃₂O₁₆

Degré de pureté : Min. 95 Area-%

Couleur et forme : White Powder

Masse moléculaire : 504.43 g/mol

Ref: 3D-OG15070